This edition provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In...more
7/5/2019
/ Accounting Standards ,
Acquisitions ,
Audit Policies ,
Board of Directors ,
CEOs ,
China ,
Conflicts of Interest ,
Controlling Stockholders ,
Criminal Prosecution ,
Disclosure Requirements ,
Disqualification ,
Due Diligence ,
Economic Sanctions ,
Enforcement Actions ,
Environmental Social & Governance (ESG) ,
Financial Reporting ,
Fines ,
Foreign Investment ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Insider Information ,
Listing Rules ,
Mergers ,
Non-GAAP Financial Measures ,
Office of Foreign Assets Control (OFAC) ,
Publicly-Traded Companies ,
Risk Assessment ,
The Market Misconduct Tribunal (MMT) ,
Trade Suspensions ,
Variable Interest Entities
In the past year, nearly a dozen companies have taken advantage of new rules to list on the Stock Exchange of Hong Kong Limited (HKEx). On April 30, 2018, HKEx introduced a series of reforms to encourage the listing of...more
6/19/2019
/ Biotechnology ,
China ,
Corporate Executives ,
Dual Class Share Structures ,
EU ,
Food and Drug Administration (FDA) ,
HKEx ,
Hong Kong Stock Exchange ,
Innovative Technology ,
Listing Rules ,
Patent Registration ,
Popular ,
Publicly-Traded Companies ,
Research and Development ,
Shareholders ,
Threshold Requirements ,
United States ,
Weighted Voting Rights (WVR)
In April 2018, the Hong Kong Stock Exchange’s (HKEx) rule amendments permitting the listing of innovative, high-growth companies with dual-class share structures and pre-revenue biotech companies went into effect. The...more
1/23/2019
/ Biotechnology ,
Capital Markets ,
Capital Raising ,
China ,
Dual Class Share Structures ,
Hong Kong ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Shanghai Stock Exchange ,
Shenzhen Stock Exchange (SZSE) ,
Stock Connect ,
Technology Sector ,
Trade Relations
After publishing the “New Board Concept Paper” in December 2017, the Stock Exchange of Hong Kong Limited (the Exchange) issued a consultation paper on February 23, 2018, titled “A Listing Regime for Companies From Emerging...more
4/26/2018
/ Biotechnology ,
China ,
Corporate Governance ,
Dual Class Share Structures ,
Emerging Technology Companies ,
Hong Kong ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Innovation ,
Listing Rules ,
Publicly-Traded Companies ,
Research and Development ,
Secondary Listings ,
Shareholder Rights ,
Voting Rights
After publishing the “New Board Concept Paper Conclusions” in December 2017, the Stock Exchange of Hong Kong Limited (the Exchange) issued on 23 February 2018 a consultation paper entitled “A Listing Regime for Companies From...more
2/26/2018
/ Biotechnology ,
China ,
Corporate Governance ,
Dual Class Share Structures ,
Emerging Technology Companies ,
HKEx ,
Hong Kong ,
Hong Kong Stock Exchange ,
Innovation ,
Investor Protection ,
Issuer Eligibility Criteria ,
Listing Rules ,
Publicly-Traded Companies ,
Research and Development ,
Secondary Listings ,
Shareholder Rights ,
Technology Sector ,
Voting Rights ,
Waivers
In October 2017 at the Chinese Communist Party National Congress, President Xi Jinping consolidated his hold on power and cemented himself as what many commentators are calling the most powerful Chinese leader since Mao...more
1/29/2018
/ Acquisitions ,
Anti-Corruption ,
Bribery ,
China ,
Debt Market ,
Enforcement Actions ,
Equity Markets ,
FinTech ,
Foreign Exchanges ,
Foreign Investment ,
Hong Kong ,
Infrastructure ,
Initial Public Offering (IPO) ,
Investment Banks ,
Mergers ,
Multinationals ,
One Belt One Road (OBOR) ,
Outbound Transactions ,
PCAOB ,
Presidential Decrees ,
Retail Investors ,
Securities Exchanges ,
State-Owned Enterprises ,
Technology Sector ,
Unicorns